← Research LibraryThe BriefFY2025 10-K · headline figures audited against SEC data
Revenue increased 2.3% to $9.47B, while Net income increased 7.5% to $2.67B.
The read at a glance✓ Audited against SEC data
- Scale — FY2025 revenue $9.47BOK
- Profitability — Net income $2.67BOK
- Cash generation — Free cash flow $2.28BOK
- Accounting — Distress score not computed · no manipulation flag · earnings quality not computedNote
- Insiders — 0 buys; 1 sells in 365 daysNote
- Capital — dividends paid were $889.0M; share repurchases were $3.23BNote
Business
Zoetis Inc.: Within each of these operating segments, we offer a diversified product portfolio for both companion animal and livestock customers so that we can capitalize on local trends and customer needs.
Where the revenue comes from
Fiscal 2025, as Zoetis Inc. reports it. History and quarterly detail are in the app.
- United States$5.1B
- International$4.3B
Leadership changes
From Zoetis Inc.'s own filings, the day they're filed.
- Louise M. Parent · Directors · departureeff. 2026-05-20
- Stephanie Tilenius · Directors · departureeff. 2025-12-01
- Robert Scully · Directors · departureeff. 2025-05-21
Latest filings
- 8-K · Company announcement2026-08-06
- 10-Q · Quarterly report2026-08-06
- 8-K · Company announcement2026-08-06
- 8-K · Company announcement2026-05-22
- 8-K · Company announcement2026-05-20
In the full recordFree for 14 days
- What changed🔒
- Insider signal🔒
- Growth quality🔒
- Margins & accounting🔒
- Capital allocation🔒
- Real risks🔒
- The long arc🔒
- Company history🔒
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, sources cited throughout🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask about Zoetis Inc., every answer cited to the official filings🔒
Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.